Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New anthracycline antibiotics.

T Oki

    The Japanese Journal of Antibiotics
    |December 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Researchers discovered new anthracycline antibiotics from Streptomyces cultures, including aclacinomycin A, to find antitumor agents with reduced cardiac toxicity. Aclacinomycin A shows promise for lower toxicity and is currently in clinical trials.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Water scarcity hotspots travel downstream due to human interventions in the 20th and 21st century.

    Nature communications·2017
    Same author

    Double-blind, placebo-controlled pilot trial of anthocyanin-rich purple sweet potato beverage on serum hepatic biomarker levels in healthy Caucasians with borderline hepatitis.

    European journal of clinical nutrition·2016
    Same author

    Cytomegalovirus infection after prophylactic valganciclovir therapy post-kidney transplantation: case reports.

    Transplantation proceedings·2012
    Same author

    Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.

    Leukemia·2011
    Same author

    Expression of ADAMTS4 in Ewing's sarcoma.

    International journal of oncology·2010
    Same author

    AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model.

    Leukemia·2010
    Same journal

    Evaluation of rapid measurement of Chlamydia trachomatis and Neisseria gonorrhoeae by using automatic gene analyzer "GENECUBE".

    The Japanese journal of antibiotics·2018
    Same journal

    Investigations on yearly changes in tebipenem susceptibility of bacterial isolates from pediatric patients -A post-marketing surveillance of tebipenem pivoxil granules for pediatric.

    The Japanese journal of antibiotics·2018
    Same journal

    Clinical analysis of the pediatric inpatients with lower respiratory tract infection due to human metapneumovirus.

    The Japanese journal of antibiotics·2018
    Same journal

    Historical and hygienic aspects on roles of quality requirements for antibiotic products in Japan: Part 5 - Introduction of technology and knowledge on streptomycin production from the United States of Americat.

    The Japanese journal of antibiotics·2018
    Same journal

    Historical and hygienic aspects on roles of quality requirements for antibiotic products in Japan: Part 4 - Enactment of requirements for individual antibiotic products.

    The Japanese journal of antibiotics·2018
    Same journal

    Visual disturbance or central symptom like hallucination in patients treated voriconazole: report of six cases.

    The Japanese journal of antibiotics·2018
    See all related articles

    Area of Science:

    • Microbiology and Natural Products Chemistry
    • Drug Discovery and Development
    • Cancer Therapeutics

    Background:

    • Adriamycin and daunomycin are potent antitumor anthracyclines but exhibit significant cardiac toxicity.
    • Existing anthracyclines have limitations in clinical use due to side effects like bone marrow suppression.
    • The search for novel anthracyclines with improved safety profiles is crucial for cancer treatment.

    Purpose of the Study:

    • To discover novel anthracycline antibiotics with potent antitumor activity and reduced cardiotoxicity.
    • To identify new compounds from Streptomyces cultures that can overcome the limitations of current therapies.
    • To investigate the structural diversity of anthracyclines and their biological activities.

    Main Methods:

    • Screening of Streptomyces cultures for the isolation of novel anthracycline compounds.

    Related Experiment Videos

  • Structural elucidation of isolated anthracyclines, including their aglycones and sugar moieties.
  • Evaluation of antitumor activity and cardiotoxicity profiles of the identified compounds.

    • Main Results:

    • Identification of 32 new anthracycline compounds from Streptomyces.
    • Aclacinomycin A, isolated from Streptomyces galilaeus MA144-M1, possesses an aklavinone aglycone.
    • Aclacinomycin A demonstrates promising low cardiac toxicity and significant antitumor potential.
    • Anthracyclines are classified into seven groups based on their aglycone structures.

    Conclusions:

    • Aclacinomycin A represents a promising candidate for a novel chemotherapeutic agent with a potentially improved safety profile.
    • The discovery of new anthracyclines expands the arsenal of anticancer drugs.
    • Further clinical studies, such as Phase II trials for aclacinomycin A, are warranted to confirm efficacy and safety.